StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a hold rating on the software maker’s stock.
Separately, Stephens boosted their target price on shares of Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a research report on Friday, January 31st.
Get Our Latest Stock Report on Veradigm
Veradigm Trading Down 4.8 %
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- How to Calculate Options Profits
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Top 3 Beverage Stocks Pouring Out Profits
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
